Andreas Halvorsen – BMRN history
- Issuer:
- BIOMARIN PHARMACEUTICAL INC
- Quarters tracked:
- 35 (Q1 2016 → Q1 2026)
- Current shares:
- 7,062,077
- Current value:
- $398.94M
- Peak shares:
- 12,288,611 (Q2 2025)
- Overall change:
- +1073%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 7,062,077 | $398.94M | $56.49 | +1,025,141 | +17% |
| Q4 2025 | 6,036,936 | $358.77M | $59.43 | -2,285,243 | -27% |
| Q3 2025 | 8,322,179 | $450.73M | $54.16 | -3,966,432 | -32% |
| Q2 2025 | 12,288,611 | $675.50M | $54.97 | +1,488,552 | +14% |
| Q1 2025 | 10,800,059 | $763.46M | $70.69 | +289,509 | +3% |
| Q4 2024 | 10,510,550 | $690.86M | $65.73 | +757,257 | +8% |
| Q3 2024 | 9,753,293 | $685.56M | $70.29 | +2,689,729 | +38% |
| Q2 2024 | 7,063,564 | $581.54M | $82.33 | +647,276 | +10% |
| Q1 2024 | 6,416,288 | $560.40M | $87.34 | +1,526,834 | +31% |
| Q4 2023 | 4,889,454 | $471.44M | $96.42 | +673,998 | +16% |
| Q3 2023 | 4,215,456 | $372.98M | $88.48 | +58,671 | +1% |
| Q2 2023 | 4,156,785 | $360.31M | $86.68 | +1,988,168 | +92% |
| Q1 2023 | 2,168,617 | $210.88M | $97.24 | -3,105,003 | -59% |
| Q4 2022 | 5,273,620 | $545.77M | $103.49 | +174,456 | +3% |
| Q3 2022 | 5,099,164 | $432.26M | $84.77 | +46,571 | +1% |
| Q2 2022 | 5,052,593 | $418.71M | $82.87 | +1,300,200 | +35% |
| Q1 2022 | 3,752,393 | $289.31M | $77.10 | +882,446 | +31% |
| Q4 2021 | 2,869,947 | $253.56M | $88.35 | +2,869,947 | +100% |
| Q2 2020 | SOLD | — | — | -1,453,625 | -100% |
| Q1 2020 | 1,453,625 | $122.83M | $84.50 | -168,114 | -10% |
| Q4 2019 | 1,621,739 | $137.12M | $84.55 | -1,436,365 | -47% |
| Q3 2019 | 3,058,104 | $206.12M | $67.40 | +467,753 | +18% |
| Q2 2019 | 2,590,351 | $221.86M | $85.65 | -2,538,558 | -49% |
| Q1 2019 | 5,128,909 | $455.60M | $88.83 | +37,272 | +1% |
| Q4 2018 | 5,091,637 | $433.55M | $85.15 | +962,696 | +23% |
| Q3 2018 | 4,128,941 | $400.38M | $96.97 | +869,184 | +27% |
| Q2 2018 | 3,259,757 | $307.07M | $94.20 | +1,577,291 | +94% |
| Q1 2018 | 1,682,466 | $136.40M | $81.07 | +1,682,466 | +100% |
| Q3 2017 | SOLD | — | — | -259,656 | -100% |
| Q2 2017 | 259,656 | $23.58M | $90.82 | -616,457 | -70% |
| Q1 2017 | 876,113 | $76.91M | $87.78 | -522,344 | -37% |
| Q4 2016 | 1,398,457 | $115.85M | $82.84 | +908,153 | +185% |
| Q3 2016 | 490,304 | $45.36M | $92.52 | +490,304 | +100% |
| Q2 2016 | SOLD | — | — | -602,116 | -100% |
| Q1 2016 | 602,116 | $49.66M | $82.48 | — | NEW |